Gwacheon-si, Gyeonggi-do, South Korea

Yong II Kim

This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong II Kim. Retrieved from https://idiyas.com/inventor/yong-ii-kim-dogf4ec7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yong II Kim: Innovator in Pharmaceutical Formulations

Introduction

Yong II Kim is a notable inventor based in Gwacheon-si, Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of composite formulations. His work is characterized by a focus on improving therapeutic efficacy and patient outcomes.

Latest Patents

Yong II Kim holds a patent for a "Pharmaceutical Composite Formulation Comprising Proton Pump Inhibitor and Antacid, and Method for Preparing Same." This innovative formulation aims to enhance the effectiveness of treatments for gastrointestinal disorders. His patent portfolio includes 1 patent, showcasing his commitment to advancing pharmaceutical science.

Career Highlights

Yong II Kim is currently employed at Hanmi Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His role at Hanmi Pharm allows him to leverage his expertise in drug formulation and development. His contributions have been instrumental in the company's efforts to deliver high-quality pharmaceutical products.

Collaborations

Due to space constraints, the details of Yong II Kim's collaborations will not be included.

Conclusion

Yong II Kim is a dedicated inventor whose work in pharmaceutical formulations has the potential to significantly impact patient care. His innovative approach and commitment to research continue to drive advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…